-+ 0.00%
-+ 0.00%
-+ 0.00%

Genmab Announces Net Sales Of DARZALEX (daratumumab) For Q1: Says Net sales Of DARZALEX Totaled $3.237B, Co Received Royalties On Worldwide Net Sales From Johnson & Johnson

Benzinga·04/15/2025 10:27:14
Listen to the news

Net trade sales were $1.829 billion in the U.S. and $1.409 billion in the rest of the world. Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC products, under the exclusive worldwide license to J&J to develop, manufacture and commercialize daratumumab.